File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Malignancies in Immunoglobulin G4-related ophthalmic disease

TitleMalignancies in Immunoglobulin G4-related ophthalmic disease
Authors
KeywordsImmunoglobulin G4 related disease
immunoglobulin G4 related ophthalmic disease
malignancies
ocular adnexal lymphoma
standardized incidence ratios
Issue Date8-Jun-2022
PublisherSAGE Publications
Citation
European Journal of Ophthalmology, 2022, v. 33, n. 1, p. 171-181 How to Cite?
Abstract

Purpose: Clinical phenotypes in Immunoglobulin G4-related disease (IgG4-RD) according to the patterns of affecting organs have different risks of malignancies. We attempt to determine the association of malignancies with IgG4-related ophthalmic disease (IgG4-ROD). Design: Retrospective cohort study. Methods: Review of medical records, orbital images and histopathology reports in a territory-wide cohort of biopsy proven IgG4-ROD patients from 2005–2019. Findings: Among 122 patients who had biopsies taken from adnexal lesions including lacrimal glands (n = 108), orbital mass (n = 30), infiltrated orbital fat (n = 10), conjunctiva (n = 2) or extraocular muscles (n = 3), 13% (16/122) developed malignancies over 73 ± 48months’ follow-up. There were 9 cases of ocular adnexal lymphoma (OAL) and 7 extra-orbital malignancies. Compared with the general population, the incidence of OAL was significantly higher (standardized incidence ratios, SIRs = 10.0, 95%CI = 4.5–17.6) while that of extra-orbital malignancies was similar. The SIRs was highest within the first year (SIR = 46.7, 95%CI = 18.5–87.6) when 7 OAL were concomitantly diagnosed. Patients who developed OAL or extra-orbital malignancies were older than other patients at IgG4-ROD diagnosis (64.9 ± 7.1, 68.3 ± 8.5 versus 55.2 ± 15.0 years, P < 0.05). Asymmetric lacrimal gland enlargement (78% versus 13%), lack of frontal (0% versus 12%) or infraorbital nerve enlargement (0% versus 36%) were associated with OAL (all P < 0.05). Pre-treatment serum IgG4 level or extra-orbital IgG4-RD involvement was similar among patients with or without malignancies. Conclusion: In this biopsy-proven IgG4-ROD cohort, 7% developed OAL which was 10 times higher than the general population. Patients with asymmetric lacrimal gland enlargement or without trigeminal nerves involvement radiologically were associated with OAL.


Persistent Identifierhttp://hdl.handle.net/10722/344900
ISSN
2023 Impact Factor: 1.4
2023 SCImago Journal Rankings: 0.686

 

DC FieldValueLanguage
dc.contributor.authorLai, Kenneth KH-
dc.contributor.authorLi, Emmy YM.-
dc.contributor.authorChan, Regine YC-
dc.contributor.authorWong, Kenneth CW-
dc.contributor.authorYu, Jimmy KS-
dc.contributor.authorCheuk, W-
dc.contributor.authorHui, YH-
dc.contributor.authorCheng, Andy CO-
dc.contributor.authorChin, Joyce KY-
dc.contributor.authorIp, SK-
dc.contributor.authorChan, WH-
dc.contributor.authorKwok, Jeremy SW-
dc.contributor.authorLam, WC-
dc.contributor.authorLo, Ida YF-
dc.contributor.authorMak, Theresa ST-
dc.contributor.authorLi, Kenneth KW-
dc.contributor.authorLam, NM-
dc.contributor.authorYip, Wilson WK-
dc.contributor.authorYoung, Alvin L-
dc.contributor.authorChan, Edwin-
dc.contributor.authorKo, Callie KL-
dc.contributor.authorKo, Simon TC-
dc.contributor.authorYuen, Hunter KL-
dc.contributor.authorTham, Clement CY-
dc.contributor.authorPang, Chi Pui-
dc.contributor.authorChong, Kelvin KL-
dc.date.accessioned2024-08-12T04:08:13Z-
dc.date.available2024-08-12T04:08:13Z-
dc.date.issued2022-06-08-
dc.identifier.citationEuropean Journal of Ophthalmology, 2022, v. 33, n. 1, p. 171-181-
dc.identifier.issn1120-6721-
dc.identifier.urihttp://hdl.handle.net/10722/344900-
dc.description.abstract<p>Purpose: Clinical phenotypes in Immunoglobulin G4-related disease (IgG4-RD) according to the patterns of affecting organs have different risks of malignancies. We attempt to determine the association of malignancies with IgG4-related ophthalmic disease (IgG4-ROD). Design: Retrospective cohort study. Methods: Review of medical records, orbital images and histopathology reports in a territory-wide cohort of biopsy proven IgG4-ROD patients from 2005–2019. Findings: Among 122 patients who had biopsies taken from adnexal lesions including lacrimal glands (n = 108), orbital mass (n = 30), infiltrated orbital fat (n = 10), conjunctiva (n = 2) or extraocular muscles (n = 3), 13% (16/122) developed malignancies over 73 ± 48months’ follow-up. There were 9 cases of ocular adnexal lymphoma (OAL) and 7 extra-orbital malignancies. Compared with the general population, the incidence of OAL was significantly higher (standardized incidence ratios, SIRs = 10.0, 95%CI = 4.5–17.6) while that of extra-orbital malignancies was similar. The SIRs was highest within the first year (SIR = 46.7, 95%CI = 18.5–87.6) when 7 OAL were concomitantly diagnosed. Patients who developed OAL or extra-orbital malignancies were older than other patients at IgG4-ROD diagnosis (64.9 ± 7.1, 68.3 ± 8.5 versus 55.2 ± 15.0 years, P < 0.05). Asymmetric lacrimal gland enlargement (78% versus 13%), lack of frontal (0% versus 12%) or infraorbital nerve enlargement (0% versus 36%) were associated with OAL (all P < 0.05). Pre-treatment serum IgG4 level or extra-orbital IgG4-RD involvement was similar among patients with or without malignancies. Conclusion: In this biopsy-proven IgG4-ROD cohort, 7% developed OAL which was 10 times higher than the general population. Patients with asymmetric lacrimal gland enlargement or without trigeminal nerves involvement radiologically were associated with OAL.</p>-
dc.languageeng-
dc.publisherSAGE Publications-
dc.relation.ispartofEuropean Journal of Ophthalmology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectImmunoglobulin G4 related disease-
dc.subjectimmunoglobulin G4 related ophthalmic disease-
dc.subjectmalignancies-
dc.subjectocular adnexal lymphoma-
dc.subjectstandardized incidence ratios-
dc.titleMalignancies in Immunoglobulin G4-related ophthalmic disease-
dc.typeArticle-
dc.identifier.doi10.1177/11206721221102274-
dc.identifier.pmid35675196-
dc.identifier.scopuseid_2-s2.0-85131516673-
dc.identifier.volume33-
dc.identifier.issue1-
dc.identifier.spage171-
dc.identifier.epage181-
dc.identifier.eissn1724-6016-
dc.identifier.issnl1120-6721-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats